Literature DB >> 7774808

Association of an activator with an RNA polymerase II holoenzyme.

C J Hengartner1, C M Thompson, J Zhang, D M Chao, S M Liao, A J Koleske, S Okamura, R A Young.   

Abstract

RNA polymerase II holoenzymes have been described that consist of RNA polymerase II, a subset of general transcription factors, and four SRB proteins. The SRB proteins, which were identified through a selection for genes involved in transcription initiation by RNA polymerase II in vivo, are a hallmark of the holoenzyme. We report here the isolation and characterization of additional SRB genes. We show that the products of all nine SRB genes identified thus far are components of the RNA polymerase II holoenzyme and are associated with a holoenzyme subcomplex termed the mediator of activation. The holoenzyme is capable of responding to a transcriptional activator, suggesting a model in which activators function, in part, through direct interactions with the holoenzyme. Immunoprecipitation experiments with anti-SRB5 antibodies demonstrate that the acidic activating domain of VP16 specifically binds to the holoenzyme. Furthermore, the holoenzyme and the mediator subcomplex bind to a VP16 affinity column. These results provide a more complete description of the RNA polymerase II holoenzyme and suggest that this form of the transcription apparatus can be recruited to promoters via direct interactions with activators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774808     DOI: 10.1101/gad.9.8.897

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  101 in total

1.  Drosophila Mediator complex is broadly utilized by diverse gene-specific transcription factors at different types of core promoters.

Authors:  J M Park; B S Gim; J M Kim; J H Yoon; H S Kim; J G Kang; Y J Kim
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  A regulatory shortcut between the Snf1 protein kinase and RNA polymerase II holoenzyme.

Authors:  S Kuchin; I Treich; M Carlson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  The role of AHA motifs in the activator function of tomato heat stress transcription factors HsfA1 and HsfA2.

Authors:  P Döring; E Treuter; C Kistner; R Lyck; A Chen; L Nover
Journal:  Plant Cell       Date:  2000-02       Impact factor: 11.277

4.  Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.

Authors:  K Ellwood; W Huang; R Johnson; M Carey
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  In vivo requirement of activator-specific binding targets of mediator.

Authors:  J M Park; H S Kim; S J Han; M S Hwang; Y C Lee; Y J Kim
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  Recruitment of the transcriptional machinery through GAL11P: structure and interactions of the GAL4 dimerization domain.

Authors:  P Hidalgo; A Z Ansari; P Schmidt; B Hare; N Simkovich; S Farrell; E J Shin; M Ptashne; G Wagner
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

8.  The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions.

Authors:  M Hagmann; O Georgiev; W Schaffner
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

10.  Requirement for a functional interaction between mediator components Med6 and Srb4 in RNA polymerase II transcription.

Authors:  Y C Lee; Y J Kim
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.